Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-12-12
2011-12-13
Yu, Misook (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100
Reexamination Certificate
active
08076460
ABSTRACT:
The present invention provides a monoclonal antibody which specifically binds to human Toll-like receptor 3 and inhibits production of type 1 interferon. It also provides an inhibitor which (a) suppresses a double-stranded RNA-mediated immune response in a cell which expresses Toll-like receptor 3 that recognizes the double-stranded RNA and produces type I interferon, and (b) includes an antibody, which binds to the Toll-like receptor 3 and inhibits production of the type I interferon. Particularly, the monoclonal antibody is against human Toll-like receptor 3. Further, a transfection method and kit are provided. Production of type I interferon can be controlled by using an antibody which specifically binds to Toll-like receptor 3 that recognizes a double-stranded RNA and produces type I interferon.
REFERENCES:
patent: 7271248 (2007-09-01), Hardiman et al.
patent: 2003/0032090 (2003-02-01), Hardiman et al.
patent: 2000-109435 (2000-04-01), None
patent: 2002-514083 (2002-05-01), None
patent: 2002-171952 (2002-06-01), None
patent: 98/22605 (1998-05-01), None
patent: 98/50547 (1998-11-01), None
patent: WO9850547 (1998-11-01), None
patent: 99/38008 (1999-07-01), None
patent: 00/18437 (2000-04-01), None
Sarkar et al (JBC 278:4393-4396, online published Dec. 30, 2002.
Cario et al Infec. &Immun. 68: 7010-17, Dec. 2000.
Matsumoto et al BBRC 293:1364-1369, May 2002, IDS, filed Jan. 6, 2009, item: QR.
Alexopoulou et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3, Nature 413:732-738 (Oct. 2001).
Kurata et al. “Differential expression of granulocyte-macrophage colony-stimulating factor and IL-3 receptor subumits on human CD34+cells and leukemic cell lines” J. Allergy Clin. Immunol. 96:1083-1099 (Dec. 1995).
Matsumoto & Seya “Recognition of dsRNA by Toll-like receptor 3” Uirusu (Virus) 51:209-214 (Dec. 2001).
Matsumoto & Seya “Functional analysis of Toll-like receptor 3” Abstract 0879, 3-B-W17-16-O/P, The 31st Annual Meeting of the Japanese Society of Immunology, Proceedings 31:232 (Dec. 2001).
Matsumoto et al. “Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling” Biochem. Biophys. Res. Comm. 293:1364-1369 (May 2002).
Matsumoto et al. “Subcellular localization of Toll-like receptor 3 in human dendritic cells” J. Immunol. 171:3154-3162 (Sep. 2003).
Price “Production and characterization of synthetic peptide-derived antibodies” in Ritter & Ladyman (eds.)Monoclonal Antibodies, Cambridge University Press, pp. 60-84 (1995).
International Search Report for PCT/JP2003/001673 dated Apr. 15, 2003.
Tachibana “A method of producing monoclonal antibodies rapidly and highly efficiently by using iliac lymph nodes of rat” Forum on Biomolecular Chemistry 21:25-28 and downloaded from http://www.chem.eng.osaka-u.ac.jp/FBC/FBCmember/FBC—NewsLetterNo21.pdf (Jun. 2006).
Ukai et al., Japanese Trial Decision for related Appln. No. JP 2002-171952, eight pages, and English translation thereof (Mar. 2009).
Matsumoto Misako
Seya Tsukasa
Japan Science and Technology Agency
Nixon & Vanderhye P.C.
Yao Lei
Yu Misook
LandOfFree
Antibody and inhibitor, and transfection method or kit using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody and inhibitor, and transfection method or kit using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody and inhibitor, and transfection method or kit using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4266336